1 reports of this reaction
4.5% of all LOBELIA INFLATA reports
#5 most reported adverse reaction
DRUG LEVEL DECREASED is the #5 most commonly reported adverse reaction for LOBELIA INFLATA, manufactured by Boiron. There are 1 FDA adverse event reports linking LOBELIA INFLATA to DRUG LEVEL DECREASED. This represents approximately 4.5% of all 22 adverse event reports for this drug.
Patients taking LOBELIA INFLATA who experience drug level decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG LEVEL DECREASED is moderately reported among LOBELIA INFLATA users, representing a notable but not dominant share of adverse events.
In addition to drug level decreased, the following adverse reactions have been reported for LOBELIA INFLATA:
DRUG LEVEL DECREASED has been reported as an adverse event in 1 FDA reports for LOBELIA INFLATA. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG LEVEL DECREASED accounts for approximately 4.5% of all adverse event reports for LOBELIA INFLATA, making it a notable side effect.
If you experience drug level decreased while taking LOBELIA INFLATA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.